Effects of Blood Pressure According to Age on End-Stage Renal Disease Development in Patients With Diabetes: A Nationwide Population-Based Cohort Study
- PMID: 35607989
- PMCID: PMC9278717
- DOI: 10.1161/HYPERTENSIONAHA.121.18881
Effects of Blood Pressure According to Age on End-Stage Renal Disease Development in Patients With Diabetes: A Nationwide Population-Based Cohort Study
Abstract
Background: Recent hypertension guidelines have recommended lower blood pressure (BP) targets in high-risk patients. However, there are no specific guidelines based on age or systolic and diastolic blood pressure (SBP and DBP, respectively). We aimed to assess the effects of age-related BP on development of end-stage renal disease (ESRD) in patients with diabetes.
Methods: A total of 2 563 870 patients with diabetes aged >20 years were selected from the Korean National Health Screening Program from 2009 to 2012 and followed up until the end of 2019. Participants were categorized into age and BP groups, and the hazard ratios for ESRD were calculated.
Results: During a median follow-up of 7.15 years, the incidence rates of ESRD increased with increasing SBP and DBP. The hazard ratio for ESRD was the highest in patients younger than 40 years of age with DBP≥100 mm Hg. The effect of SBP and DBP on ESRD development was attenuated with age (interaction P was <0.0001 for age and SBP, and 0.0022 for age and DBP). The subgroup analysis for sex, antihypertension medication, and history of chronic kidney disease showed higher hazard ratios for ESRD among males, younger than 40 years, not taking antihypertension medications and chronic kidney disease compared to those among females, older than 40 years, antihypertension medication, and nonchronic kidney disease groups.
Conclusions: Higher SBP and DBP increase the risk of developing ESRD in patients with diabetes, and in particular, younger individuals face greater risk. Therefore, intensive BP management is warranted in younger patients to prevent ESRD.
Keywords: blood pressure; cardiovascular diseases; hypertension; kidney diseases; young adult.
Figures

Comment in
-
Bei Diabetes frühzeitig auf den Blutdruck achten.MMW Fortschr Med. 2022 Nov;164(19):27-28. doi: 10.1007/s15006-022-2041-2. MMW Fortschr Med. 2022. PMID: 36310266 Review. German. No abstract available.
Similar articles
-
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.Am J Hypertens. 2012 Jul;25(7):789-96. doi: 10.1038/ajh.2012.48. Epub 2012 May 10. Am J Hypertens. 2012. PMID: 22573012 Free PMC article.
-
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).Arch Intern Med. 2012 Jan 9;172(1):41-7. doi: 10.1001/archinternmed.2011.619. Arch Intern Med. 2012. PMID: 22232147 Free PMC article.
-
Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study.Sci Rep. 2021 Jan 15;11(1):1538. doi: 10.1038/s41598-021-81328-y. Sci Rep. 2021. PMID: 33452422 Free PMC article.
-
Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.J Hypertens. 2017 May;35(5):922-944. doi: 10.1097/HJH.0000000000001276. J Hypertens. 2017. PMID: 28141660 Review.
-
Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 - benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials.J Hypertens. 2018 Aug;36(8):1622-1636. doi: 10.1097/HJH.0000000000001787. J Hypertens. 2018. PMID: 29847485 Review.
Cited by
-
Increased end-stage renal disease risk in age-related macular degeneration: a nationwide cohort study with 10-year follow-up.Sci Rep. 2023 Jan 5;13(1):183. doi: 10.1038/s41598-022-26964-8. Sci Rep. 2023. PMID: 36604459 Free PMC article.
-
Canagliflozin on top of dual renin-angiotensin system blockade in a woman with partial acquired lipodystrophy, type 2 diabetes and severely proteinuric chronic kidney disease: a case report.Front Endocrinol (Lausanne). 2023 May 19;14:1172468. doi: 10.3389/fendo.2023.1172468. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37274321 Free PMC article.
-
Blood pressure levels and risk of end-stage renal disease in patients with type 2 diabetes who underwent percutaneous coronary intervention: a nationwide population-based study.Sci Rep. 2025 Mar 6;15(1):7832. doi: 10.1038/s41598-025-91835-x. Sci Rep. 2025. PMID: 40050367 Free PMC article.
-
Kidney function trajectories, associated factors, and outcomes in multiethnic Asian patients with type 2 diabetes.J Diabetes. 2024 Sep;16(9):e13523. doi: 10.1111/1753-0407.13523. Epub 2024 Jan 2. J Diabetes. 2024. PMID: 38169157 Free PMC article.
-
The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study.Cardiovasc Diabetol. 2022 Dec 6;21(1):273. doi: 10.1186/s12933-022-01691-6. Cardiovasc Diabetol. 2022. PMID: 36474232 Free PMC article.
References
-
- Kastarinen M, Juutilainen A, Kastarinen H, Salomaa V, Karhapää P, Tuomilehto J, Grönhagen-Riska C, Jousilahti P, Finne P. Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland. J Intern Med. 2010;267:612–620. doi: 10.1111/j.1365-2796.2009.02197.x - PubMed
-
- Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, et al. ; American Heart Association, American College of Cardiology, and American Society of Hypertension. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the american heart association, american college of cardiology, and american society of hypertension. Circulation. 2015;131:e435–e470. doi: 10.1161/CIR.0000000000000207 - PMC - PubMed
-
- Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, et al. . 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC). Eur Heart J. 2013;34:2159–2219. doi: 10.1093/eurheartj/eht151 - PubMed
-
- Hinton TC, Adams ZH, Baker RP, Hope KA, Paton JFR, Hart EC, Nightingale AK. Investigation and treatment of high blood pressure in young people: too much medicine or appropriate risk reduction? Hypertension. 2020;75:16–22. doi: 10.1161/HYPERTENSIONAHA.119.13820 - PubMed
-
- Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, et al. . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71:e13–e115. doi: 10.1161/HYP.0000000000000065 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical